House Bill 601
116th Congress(2019-2020)
Medical Cannabis Research Act of 2019
Introduced
Introduced in House on Jan 16, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
601
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Medical Cannabis Research Act of 2019
This bill establishes a new, separate registration process for manufacturers of cannabis for research.
As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.
The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
January 16, 2019
03/04/2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
02/08/2019
Referred to the Subcommittee on Health.
01/25/2019
Referred to the Subcommittee on Health.
01/16/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/16/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 2:17:29 PM